Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Yoshiaki Ishigatsubo, Takayoshi Tachibana et al.|Leukemia Research|2015Cited by 35
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Medical Oncology|2014Cited by 15
Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective studyTakuma Ohashi, Jun Aoki, Taiki Ando et al.|Bone Marrow Transplantation|2022Cited by 9
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) studyYoshimi Ishii, Hideaki Nakajima, Shin Fujisawa et al.|Asia-Pacific Journal of Clinical Oncology|2018Cited by 7
Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin LymphomaYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Blood|2013Cited by 4